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Available online 18 October 2010There is great interest in finding an effective pharmacolog-
ical agent for the treatment of abdominal aortic aneurysms
(AAA). Since Schouten et al.1 published their article in 2006,
much hope has been placed on statin treatment to slowdown
AAA growth. But evidence of the effects of statins on AAA
natural history has been confusing in the last few years. A
recentmeta-analysis of clinical controlled studies hasproved
a significant association of statins and reduced AAA growth
rates.2 Still, none of the published studies are randomized
and not all studies report favourable results.3e5 Indeed,
a randomized controlled trial seems essential to assess the
true impact of statin treatment onAAAevolution but it would
find great difficulty given the proven beneficial effect of the
medication on overall cardiovascular risk and the massive
current demand and prescription,making a potential control
group limited and possibly unethical.
Dawson et al. found a significant reduction in AAA wall
MMP-9 and IL-6 from patients treated with simvastatin
40 mg þ ezetimibe 10 mg compared to simvastatin alone.
Concentrations of other inflammatory or proteolytic enzymesDOI of original article: 10.1016/j.ejvs.2010.08.023.
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doi:10.1016/j.ejvs.2010.09.023were similar in both groups and none of the 15 evaluated
plasma proteins showed any significant differences. The
authorsaddsome informationto the timely issueof statinsand
AAA but their study is limited by a small sample size and short
treatment and by the fact that the tissue and plasma
concentrationsof someof the studiedproteinswerebelowthe
recordable levels of the assay and so inconclusive. Their
results inspire more questions than answers. The reduction in
aortic wall proteolysis and inflammation seems very limited
andcouldbeachancefinding. Andevenwhentheeffectmight
be measurable on the AAA wall, the behaviour and conse-
quences of localized inflammatory activity are still fairly
unclear and, ultimately, it is theAAAexpansion rates andmost
importantly the AAA rupture risk that the different potential
pharmacological treatmentsmustproveuseful in limiting.The
published results are only preliminary, still insufficient to
establish oreven clarify the role of ezetimibe in the treatment
of AAA. Much further research is needed.
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